Skip to content

Clinical trials

Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 2 Country / region: Germany Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20053
20063
20072
20082
20102
20121
20131
20151
20162
20182
20191
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated4
Active, not recruiting3
Withdrawn1
Recruiting1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Bristol-Myers Squibb6
European Society for Blood and Marrow Transplantation2
Fred Hutchinson Cancer Center2
Teva Branded Pharmaceutical Products R&D, Inc.2
Thomas Ernst, PD Dr. med.2
Ariad Pharmaceuticals1
Cancer Trials Ireland1
European LeukemiaNet1
GWT-TUD GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive31
Leukemia6
Blast Crisis4
Leukemia, Myeloid, Chronic-Phase4
Philadelphia Chromosome4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Leukemia, Myeloid, Acute3
Hematologic Diseases2
Hodgkin Disease2
Leukemia, Myeloid2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.